Abramson Cancer Center of The University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Abramson Cancer Center of The University of Pennsylvania has participated in 38 clinical trials with 2 currently active.
Therapeutic areas: Diffuse Large B-Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Hematopoietic/Lymphoid Cancer.
Sponsors: Debiopharm International SA, University of Pennsylvania, Abramson Cancer Center at Penn Medicine.
Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Abramson Cancer Center of The University of Pennsylvania has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Abramson Cancer Center of The University of Pennsylvania has 38 clinical trials on record, with 2 currently active. Their work covers Diffuse Large B-Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Hematopoietic/Lymphoid Cancer.
Yes — Abramson Cancer Center of The University of Pennsylvania holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.